HealthCare Global Enterprises Limited (NSE:HCG)

Market Cap	98.53B +28.0%
Revenue (ttm)	25.45B +15.6%
Net Income	137.60M -69.0%
EPS	0.96 -69.4%
Shares Out	149.30M
PE Ratio	716.08
Forward PE	75.66
Dividend	n/a
Ex-Dividend Date	n/a

Volume	90,211
Open	663.00
Previous Close	656.00
Day's Range	651.80 - 664.00
52-Week Range	513.30 - 804.65
Beta	-0.14
Analysts	Strong Buy
Price Target	779.56 (+18.13%)
Earnings Date	May 19, 2026

About NSE:HCG

HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncology, radiation and surgical oncology, molecular imaging and theranostics, chemotherapy, robotic surgery, actinium and lutetium therapy, immunotherapy, ...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1989
• Employees: 6,736
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: HCG

Financial Performance

In fiscal year 2026, NSE:HCG's revenue was 25.70 billion, an increase of 15.64% compared to the previous year's 22.23 billion. Earnings were 137.60 million, a decrease of -69.02%.